Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald P Goldstein

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|November 3, 2017
Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experienceIzildinha Maestá, Roni Nitecki, Neil S Horowitz, et al.
The Journal of Reproductive Medicine|July 19, 2016
Maternal Near Miss According to World Health Organization Classification Among Women with a Hydatidiform Mole: Experience at the New England Trophoblastic Disease Center, 1994-2013Sue Yazaki Sun, Donald P Goldstein, Marilyn R Bernstein, et al.
Gynecologic Oncology|December 9, 2008
Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasiaWhitfield B Growdon, Adam J Wolfberg, Donald P Goldstein, et al.
Gynecologic Oncology|January 19, 2016
The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancyAllison A Gockley, Alexander Melamed, Naima T Joseph, et al.
The Journal of Reproductive Medicine|October 2, 2004
Predictors of quality of life among long-term survivors of gestational trophoblastic diseaseLari Wenzel, Ross S Berkowitz, Rana Habbal, et al.
Gynecologic Oncology|August 4, 2016
Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for ageAlexander Melamed, Allison A Gockley, Naima T Joseph, et al.
Gynecologic Oncology|July 18, 2016
Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasiaRenan Rocha Soares, Izildinha Maestá, José Colón, et al.
Gynecologic Oncology|May 14, 2015
Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?Sue Yazaki Sun, Alexander Melamed, Donald P Goldstein, et al.
Obstetrics and Gynecology|August 2, 2006
Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancyAdam J Wolfberg, Whitfield B Growdon, Colleen M Feltmate, et al.
American Journal of Obstetrics and Gynecology|May 1, 2016
Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral centerAllison A Gockley, Naima T Joseph, Alexander Melamed, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|November 3, 2017
Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experienceIzildinha Maestá, Roni Nitecki, Neil S Horowitz, et al.
The Journal of Reproductive Medicine|July 19, 2016
Maternal Near Miss According to World Health Organization Classification Among Women with a Hydatidiform Mole: Experience at the New England Trophoblastic Disease Center, 1994-2013Sue Yazaki Sun, Donald P Goldstein, Marilyn R Bernstein, et al.
Gynecologic Oncology|December 9, 2008
Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasiaWhitfield B Growdon, Adam J Wolfberg, Donald P Goldstein, et al.
Gynecologic Oncology|January 19, 2016
The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancyAllison A Gockley, Alexander Melamed, Naima T Joseph, et al.
The Journal of Reproductive Medicine|October 2, 2004
Predictors of quality of life among long-term survivors of gestational trophoblastic diseaseLari Wenzel, Ross S Berkowitz, Rana Habbal, et al.
Gynecologic Oncology|August 4, 2016
Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for ageAlexander Melamed, Allison A Gockley, Naima T Joseph, et al.
Gynecologic Oncology|July 18, 2016
Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasiaRenan Rocha Soares, Izildinha Maestá, José Colón, et al.
Gynecologic Oncology|May 14, 2015
Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?Sue Yazaki Sun, Alexander Melamed, Donald P Goldstein, et al.
Obstetrics and Gynecology|August 2, 2006
Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancyAdam J Wolfberg, Whitfield B Growdon, Colleen M Feltmate, et al.
American Journal of Obstetrics and Gynecology|May 1, 2016
Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral centerAllison A Gockley, Naima T Joseph, Alexander Melamed, et al.
Pageof 7